Novo-Nordisk A/S News

Canto Fitzgerald: The Novo Nordisk (NVO.US) rating was reaffirmed and adjusted from an increase in holdings to an increase rating, with a target price of $160.00.

Zhitong FinanceApr 18 22:01

Novo Nordisk Analyst Ratings

BenzingaApr 18 21:58

Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price Target

BenzingaApr 18 21:59

Novo Nordisk (NVO.US) was first covered by the Bank of Montreal in Canada, giving it an superior market rating, with a target price of $163.00.

Zhitong FinanceApr 12 17:21

Novo Nordisk Analyst Ratings

BenzingaApr 12 17:13

Novo Nordisk Analyst Ratings

BenzingaApr 5 21:31

Novo Nordisk Analyst Ratings

BenzingaApr 1 20:38

Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price Target

BenzingaApr 1 20:39

Novo Nordisk Analyst Ratings

BenzingaMar 20 20:54

Novo Nordisk Analyst Ratings

BenzingaMar 9 01:35

Novo Nordisk Analyst Ratings

BenzingaFeb 21 01:42

Novo Nordisk Analyst Ratings

BenzingaFeb 15 00:32

Cantor Fitzgerald Raises Price Target on Novo Nordisk to $140 From $120, Keeps Overweight Rating

MT NewswiresFeb 1 21:19

Novo Nordisk Analyst Ratings

BenzingaJan 23 18:36

Amgen Upgraded at RBC on Catalyst Setup and Growth Drivers

Seeking AlphaDec 13, 2023 00:51

TD Cowen Maintains Outperform on Novo Nordisk, Raises Price Target to $115

BenzingaDec 5, 2023 01:27

Novo Nordisk Analyst Ratings

BenzingaDec 5, 2023 01:25

Cantor Fitzgerald Initiates Coverage On Novo Nordisk With Overweight Rating, Announces Price Target of $120

BenzingaDec 1, 2023 21:49

Novo Nordisk Analyst Ratings

BenzingaDec 1, 2023 21:47

ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone

Seeking AlphaOct 10, 2023 03:19